Stockholm: Östgötagatan 100, SE 116 64 Stockholm, Sweden Tel. +46 (0) 8 545 785 00
Manchester: F3.1 Adelphi Mill, Bollington, Macclesfield SK10 5JB, UK Tel. +44 (0) 1625 5764 44
Manchester: F3.1 Adelphi Mill, Bollington, Macclesfield SK10 5JB, UK Tel. +44 (0) 1625 5764 44
Hate needles. Love emla™.
Social media helps people share their stories
11 June 2008
We are proud to announce the release of the emla™ campaign website at www.ihateneedles.co.uk on behalf of AstraZeneca.
Our client's main purpose with the campaign is to increase awareness with consumers about the local anaesthetic cream and its intended uses.
AstraZeneca generously gave us the freedom to drive the overall concept, design and development of both the emla campaign site and the accompanying banner campaign.
At the heart of the campaign is a social media initiative where people are encouraged to share their emla stories by uploading photos or videos. Visitors to the site can even record a video message straight in to the website using their web cams, making it even easier to participate.
The stories are then voted and commented on by the site's visitors and at the end of the campaign the winners will receive prizes from AstraZeneca.
Daniel Bevan oversaw the project on behalf of Orbitsville.
Daniel Selby (Commercial Brand Manager) at AstraZeneca:
The emla campaign site is live at www.ihateneedles.co.uk
About Orbitsville
At Orbitsville we create online marketing campaigns and web applications that people want to spend time with. For our clients this means a more effective way to reach the people that matter, and for their audiences a better and more meaningful interaction with our clients’ brands. We are headquartered in Stockholm, with offices in Manchester. Orbitsville is privately owned and a founding member of the Arcturos Group.
Orbitsville
www.orbitsville.com
About AstraZeneca
AstraZeneca is dedicated to the discovery, development, manufacture and marketing of medicines for important areas of healthcare, including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. In the UK alone, AstraZeneca spends around £750 million each year on researching and developing new medicines, and is committed to working in partnership with the NHS across the UK to make a difference to the health of the nation.
AstraZeneca
www.astrazeneca.co.uk
Media enquires
Jaan Orvet
media@orbitsville.com
+1 415 287 7615
News feed
Subscribe to Orbitsville’s news feed for the latest updates and announcements feeds.feedburner.com/orbitsvillenews
emla is a registered trademark of the AstraZeneca group of companies
Date of Preparation May 2008 C15074
Back
We are proud to announce the release of the emla™ campaign website at www.ihateneedles.co.uk on behalf of AstraZeneca.
Our client's main purpose with the campaign is to increase awareness with consumers about the local anaesthetic cream and its intended uses.
AstraZeneca generously gave us the freedom to drive the overall concept, design and development of both the emla campaign site and the accompanying banner campaign.
At the heart of the campaign is a social media initiative where people are encouraged to share their emla stories by uploading photos or videos. Visitors to the site can even record a video message straight in to the website using their web cams, making it even easier to participate.
The stories are then voted and commented on by the site's visitors and at the end of the campaign the winners will receive prizes from AstraZeneca.
Daniel Bevan oversaw the project on behalf of Orbitsville.
"We created a foundation for AstraZeneca to gather information about the different types of problems people have with needlephobia and skin discomfort. The stories about the issues people face automatically reveal the benefits of utilising emla cream.
This is the first time a pharmaceutical company in the UK has used social media in this way. It is a groundbreaking project."
This is the first time a pharmaceutical company in the UK has used social media in this way. It is a groundbreaking project."
Daniel Selby (Commercial Brand Manager) at AstraZeneca:
"We want to take ‘word of mouth’ to the next level by using different social media channels. This campaign will allow people to spread the word about emla in a more effective and personal way than before."
The emla campaign site is live at www.ihateneedles.co.uk
About Orbitsville
At Orbitsville we create online marketing campaigns and web applications that people want to spend time with. For our clients this means a more effective way to reach the people that matter, and for their audiences a better and more meaningful interaction with our clients’ brands. We are headquartered in Stockholm, with offices in Manchester. Orbitsville is privately owned and a founding member of the Arcturos Group.
Orbitsville
www.orbitsville.com
About AstraZeneca
AstraZeneca is dedicated to the discovery, development, manufacture and marketing of medicines for important areas of healthcare, including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. In the UK alone, AstraZeneca spends around £750 million each year on researching and developing new medicines, and is committed to working in partnership with the NHS across the UK to make a difference to the health of the nation.
AstraZeneca
www.astrazeneca.co.uk
Media enquires
Jaan Orvet
media@orbitsville.com
+1 415 287 7615
News feed
Subscribe to Orbitsville’s news feed for the latest updates and announcements feeds.feedburner.com/orbitsvillenews
emla is a registered trademark of the AstraZeneca group of companies
Date of Preparation May 2008 C15074
Back